Firebrick Pharma Limited (AU:FRE) has released an update.
Firebrick Pharma Limited has announced a new securities issue set for 31st May 2024, comprising 8 million unlisted options and 16 million ordinary fully paid shares. This strategic move aims to generate capital and expand the company’s financial horizons. Interested investors are advised to keep an eye on this development as Firebrick Pharma enters a significant phase of growth.
For further insights into AU:FRE stock, check out TipRanks’ Stock Analysis page.